Clinical Trial Update: Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

The document reports a Phase 3 trial evaluating Sintilimab plus chemotherapy as neoadjuvant and adjuvant therapy for locally advanced oral squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Qunxing Li,MD | Conditions: Locally Advanced Oral Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma (OSCC) | Phase 3 | Status: RECRUITING